Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Vu

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
F&S Reports|August 8, 2022
Provision of infertility care for the underserved in reproductive endocrinology and infertility practices associated with obstetrics and gynecology residency training programs in the United StatesTia Jackson-Bey, Holly Mehr, Jacqueline R Ho, et al.
Pediatric Pulmonology|November 2, 2018
Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016Scott D Grosse, Thuy Quynh N Do, Michelle Vu, et al.
Journal of Assisted Reproduction and Genetics|April 18, 2021
We are here for you: infertility clinic communication during the first wave of the COVID-19 pandemicHolly Mehr, Tia Jackson-Bey, Michelle Vu, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United StatesOralee J Varnado, Michelle Vu, Erin Buysman, et al.
Journal of Medical Economics|March 10, 2025
Adverse consequences of systemic corticosteroids use among a broad population of US adults with asthma: a real-world analysisSandra Sze-Jung Wu, Michelle Vu, Omar Motawakel, et al.
Current Medical Research and Opinion|February 9, 2024
Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims studyOralee J Varnado, Michelle Vu, Erin K Buysman, et al.
Journal of Managed Care & Specialty Pharmacy|March 29, 2023
Increased delay from initial concern to diagnosis of autism spectrum disorder and associated health care resource utilization and cost among children aged younger than 6 years in the United StatesMichelle Vu, Amy M Duhig, Abhishek Tibrewal, et al.
Journal of Health Economics and Outcomes Research|June 30, 2025
Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients with Multifocal Motor Neuropathy: A US Claims Database Cohort StudyNikhil Khandelwal, Marie Sanchirico, Ade Ajibade, et al.
Patient Preference and Adherence|March 6, 2025
Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims StudyOralee J Varnado, Michelle Vu, Erin K Buysman, et al.
JAMA Network Open|October 5, 2020
Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care SystemMichelle Vu, Kathryn Tortorice, Jennifer Zacher, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
F&S Reports|August 8, 2022
Provision of infertility care for the underserved in reproductive endocrinology and infertility practices associated with obstetrics and gynecology residency training programs in the United StatesTia Jackson-Bey, Holly Mehr, Jacqueline R Ho, et al.
Pediatric Pulmonology|November 2, 2018
Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016Scott D Grosse, Thuy Quynh N Do, Michelle Vu, et al.
Journal of Assisted Reproduction and Genetics|April 18, 2021
We are here for you: infertility clinic communication during the first wave of the COVID-19 pandemicHolly Mehr, Tia Jackson-Bey, Michelle Vu, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United StatesOralee J Varnado, Michelle Vu, Erin Buysman, et al.
Journal of Medical Economics|March 10, 2025
Adverse consequences of systemic corticosteroids use among a broad population of US adults with asthma: a real-world analysisSandra Sze-Jung Wu, Michelle Vu, Omar Motawakel, et al.
Current Medical Research and Opinion|February 9, 2024
Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims studyOralee J Varnado, Michelle Vu, Erin K Buysman, et al.
Journal of Managed Care & Specialty Pharmacy|March 29, 2023
Increased delay from initial concern to diagnosis of autism spectrum disorder and associated health care resource utilization and cost among children aged younger than 6 years in the United StatesMichelle Vu, Amy M Duhig, Abhishek Tibrewal, et al.
Journal of Health Economics and Outcomes Research|June 30, 2025
Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients with Multifocal Motor Neuropathy: A US Claims Database Cohort StudyNikhil Khandelwal, Marie Sanchirico, Ade Ajibade, et al.
Patient Preference and Adherence|March 6, 2025
Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims StudyOralee J Varnado, Michelle Vu, Erin K Buysman, et al.
JAMA Network Open|October 5, 2020
Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care SystemMichelle Vu, Kathryn Tortorice, Jennifer Zacher, et al.
Pageof 7